About the Company
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CDXS News
Codexis to Report First Quarter 2024 Financial Results on May 2
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 ...
Codexis (NASDAQ: CDXS)
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
REDWOOD CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Carole Cobb, MBA, to the Company’s ...
Codexis: Q4 Earnings Snapshot
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Wednesday reported a loss of $7.2 million in its fourth quarter. The Redwood City, California-based company said ...
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ...
Codexis Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect
Codexis, Inc CDXS has an Earnings ESP of +81.25% and a Zacks Rank #2 at present. CDXS is scheduled to report fourth-quarter fiscal 2023 earnings on Feb 28. You can see the complete list of today ...
Codexis Inc
*Each quarterly filing is treated as a separate report. Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, ...
Loading the latest forecasts...